市場調查報告書

兒科藥物全球市場(2020-2026)

Global Pediatric Drugs Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949483
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
兒科藥物全球市場(2020-2026) Global Pediatric Drugs Market 2020-2026
出版日期: 2020年05月30日內容資訊: 英文
簡介

預計在預測期內,全球兒科市場將呈現顯著增長。世界範圍內兒童疾病的流行是全球兒科市場需求的主要驅動力。 FDA對兒科護理中使用的各種藥物的批准不斷增加,為預測期內的市場增長創造了更多重要機會。

兒科藥物市場是根據藥物類型,給藥途徑和應用進行細分的。根據藥物類型,市場分為過敏和呼吸道疾病,癌症治療,心血管疾病,胃腸道疾病等。按照管理途徑,市場分為口頭,局部,腸胃外和其他市場。按照應用,它分為兒科臨床藥理學,兒科藥物治療和兒科藥房。

在地理上,全球兒科市場分為北美,歐洲,亞太地區和其他國家。預計北美將在全球市場中佔有很大的市場份額。該地區的增長主要由美國發達的醫療基礎設施推動。此外,Genetech Inc.,Abbott Laboratories Inc.和Johnson&Johnson等主要市場參與者的存在是促進該地區兒科藥物市場增長的另一個因素。預計在預測期內,亞太地區在全球市場將有顯著增長。

全球兒科藥物市場主要受到市場上領先企業的產品開發和進步的影響。兒科市場的主要參與者包括諾華國際公司,Allergan PLC,強生公司,F。Hoffman La Roche,輝瑞,勃林格殷格翰國際有限公司,葛蘭素史克公司,百時美施貴寶,禮來公司等。包括公司等。兒科市場上領先的市場參與者在採取幾種戰略(包括併購,合夥關係和協作)方面尤其積極。

該報告調查了全球兒科藥物市場,市場概況,市場增長因素和障礙因素的分析,市場規模趨勢以及按藥物類型,給藥途徑,應用和地區以及競爭劃分的預測。它提供有關情況,主要公司的概況,市場機會等的系統信息。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 公司份額分析
  • 主要策略分析
  • 主要公司分析
    • 諾華國際公司
    • 百時美施貴寶公司
    • 霍夫曼拉羅氏有限公司
    • Merck KGaA
    • 艾爾建(Allergan)PLC

第4章市場決定因素

  • 動機
  • 抑制因子
  • 市場機會

第5章市場細分

  • 按藥物類型
    • 過敏和呼吸內科
    • 癌症治療
    • 心血管藥物
    • 胃腸道藥物
    • 其他
  • 通過管理途徑
      口語
    • 本地
    • 腸胃外
    • 其他(口腔)
  • 通過申請
    • 兒科臨床藥理學
    • 兒科藥物治療
    • 兒科藥房

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • Abbott Laboratories Inc.
  • Allergan PLC
  • AstraZeneca PLC
  • AYTU BioScience, Inc.
  • Bayer AG
  • BioMarin Pharmaceutical, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Eisai Inc
  • Eli Lilly Co.
  • F. Hoffman La Roche, Ltd.
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson, Inc.
  • Mallinckrodt PLC
  • Merck KGaA
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries, Ltd.
目錄
Product Code: OMR2021802

Global Pediatric Drugs Market Size, Share & Trends Analysis Report, by Drug Type (Allergy and Respiratory Drugs, Cancer Therapies, Cardiovascular Drugs, Gastrointestinal Drugs, and Others), by Route of Administration (Oral, Topical, Parenteral, and Other), by Application (Pediatric Clinical Pharmacology, Pediatric Pharmacotherapy, and Pediatric Pharmacy) Forecast Period (2020-2026)

The global pediatric drug market is projected to witness considerable growth during the forecast period. The growing prevalence of pediatric disorders across the globe is a key factor responsible for the demand for pediatric drugs market across the globe. The growing FDA approvals for different drugs that are used to treat pediatrics are further creating a huge opportunity for market growth during the forecast period.

The pediatric drugs market is segmented on the basis of drug type, route of administration, and application. Based on drug type, the market is segmented into allergy and respiratory drugs, cancer therapies, cardiovascular drugs, gastrointestinal drugs, and others. Based on the route of administration, the market is segmented into oral, topical, parenteral, and other. Based on the application, the market is segmented into pediatric clinical pharmacology, pediatric pharmacotherapy, and pediatric pharmacy.

Geographically, the global pediatric drug market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. North America is anticipated to have a significant market share in the global market. The growth of the region is being primarily driven by the well-developed healthcare infrastructure of the US. In addition, the presence of the major market players such as Genetech Inc., Abbott Laboratories, Inc., Johnson & Johnson among others is another factor attributing towards the growth of the pediatric drugs market in the region. Asia-Pacific is estimated to have considerable growth in the global market during the forecast period.

The global pediatric drug market is mainly influenced by product development and advancements conducted by the key players operating in the market. The key players of the Pediatric drugs market include Novartis International AG, Allergan PLC, Johnson & Johnson Services Inc., F. Hoffman La Roche, Pfizer Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly and Co., among others. The key market players operating in the pediatric drug market are actively adopting several strategies such as merger and acquisition, partnerships and collaboration among others.

Research Methodology

The market study of the global pediatric drugs market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Pediatric Drugs Market Research and Analysis by Drug Type

2. Global Pediatric Drugs Market Research and Analysis by Route of Administration

3. Global Pediatric Drugs Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global pediatric drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global pediatric drugs market.
  • Insights about market determinants which are stimulating the global pediatric drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Novartis International AG
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Bristol-Myers Squibb Co.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. F. Hoffman La Roche, Ltd.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Merck KGaA
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Allergan PLC
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.1. Opportunities

5. Market Segmentation

  • 5.1. Global Pediatric Drugs Market by Drug Type
    • 5.1.1. Allergy and Respiratory Drugs
    • 5.1.2. Cancer Therapies
    • 5.1.3. Cardiovascular Drugs
    • 5.1.4. Gastrointestinal Drugs
    • 5.1.5. Others
  • 5.2. Global Pediatric Drugs Market by Route of Administration
    • 5.2.1. Oral
    • 5.2.2. Topical
    • 5.2.3. Parenteral
    • 5.2.4. Other (Buccal)
  • 5.3. Global Pediatric Drugs Market by Application
    • 5.3.1. Pediatric Clinical Pharmacology
    • 5.3.2. Pediatric Pharmacotherapy
    • 5.3.3. Pediatric Pharmacy

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Allergan PLC
  • 7.3. AstraZeneca PLC
  • 7.4. AYTU BioScience, Inc.
  • 7.5. Bayer AG
  • 7.6. BioMarin Pharmaceutical, Inc.
  • 7.7. Boehringer Ingelheim International GmbH
  • 7.8. Bristol-Myers Squibb Co.
  • 7.9. Eisai Inc
  • 7.10. Eli Lilly Co.
  • 7.11. F. Hoffman La Roche, Ltd.
  • 7.12. Genentech, Inc.
  • 7.13. GlaxoSmithKline PLC
  • 7.14. Johnson & Johnson, Inc.
  • 7.15. Mallinckrodt PLC
  • 7.16. Merck KGaA
  • 7.17. Novartis International AG
  • 7.18. Novo Nordisk A/S
  • 7.19. Pfizer, Inc.
  • 7.20. Teva Pharmaceutical Industries, Ltd.

LIST OF TABLES

  • 1. GLOBAL PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL ALLERGY AND RESPIRATORY DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL CANCER THERAPIES MARKET RESEARCH AND ANALYSIS BY REGION,2019-2026 ($ MILLION)
  • 4. GLOBAL CARDIOVASCULAR DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL GASTROINTESTINAL DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 8. GLOBAL ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL TOPICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 10. GLOBAL PARENTERAL MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 12. GLOBAL PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 13. GLOBAL PEDIATRIC CLINICAL PHARMACOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 14. GLOBAL PEDIATRIC PHARMACOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 15. GLOBAL PEDIATRIC PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 16. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 17. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
  • 18. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 19. NORTH AMERICAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 20. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 21. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
  • 22. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 23. EUROPEAN PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 24. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 25. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
  • 26. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 27. ASIA-PACIFIC PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 28. REST OF THE WORLD PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2019-2026 ($ MILLION)
  • 29. REST OF THE WORLD PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 30. REST OF THE WORLD PEDIATRIC DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY DRUG TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY ROUTE OF ADMINISTRATION, 2019 VS 2026 (%)
  • 3. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
  • 4. GLOBAL PEDIATRIC DRUGS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 5. THE US PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. CANADA PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. UK PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. FRANCE PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. GERMANY PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ITALY PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. SPAIN PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. ROE PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. INDIA PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. CHINA PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. JAPAN PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)

17. REST OF THE WORLD PEDIATRIC DRUGS MARKET SIZE, 2019-2026 ($ MILLION)